Search

Respimat re-usable wins Pharmapack Eco-Design Award

The Respimat® re-usable inhaler device has won the 2020 Pharmapack Eco-Design Award. An enhanced version of the Respimat® soft mist inhaler, Respimat® re-usable has a lower environmental impact and is easy for patients to use.

Classical Swine Fever live vaccine approved in China

Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved

Health for all: How can we contribute to inclusive access?

What drives us to improve the health of humans and animals worldwide

preserved-heart-failure-treatment-FDA-US-approval

US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction

emperor-reduced-heart-failure-toplineresults

Positive, top-line results announced from the EMPEROR-Reduced Phase III trial in adults with chronic heart failure with reduced ejection fraction

preserved-heart-failure-treatment-approval-europe

Equestrian sports horse health awareness Alex Hua Tian

Together with Olympian trailblazer and eventer Alex Hua Tian, we educate about equine health in China.

CAROLINA-CARMELINA-Asia-analysis

CAROLINA® and CARMELINA® outcome trial subgroup analyses demonstrate cardiovascular and renal safety data in Asian adults with type 2 diabetes

The impact of carbon reduction projects

Boehringer Ingelheim voluntarily contributes to carbon reduction projects that benefit sustainable development.

new_analysis_nintedanib_SSc_ILD

Interim analysis results support long term treatment with nintedanib in SSc-ILD patients

RE-LY-trial-publication-10-year-anniversary

Boehringer Ingelheim recognises the contribution made in the decade since the RE-LY® trial publication by patients, HCPs and researchers

The Angels Initiative

The Angels Initiative helps hospitals around the world become ‘stroke-ready’ so that stroke patients can be treated as quickly and effectively as possible.

U.S. FDA approves first treatment for generalized pustular psoriasis flares in adults

Boehringer Ingelheim announces the U.S. FDA has approved the first treatment for generalized pustular psoriasis (GPP) flares in adults

empa-reg-outcome-recurrent-events

EMPA-REG OUTCOME® analysis: Empagliflozin reduced risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and CV disease

Boehringer receives SBTi validation for CO2 reduction targets

Boehringer Ingelheim receives SBTi validation for CO2 reduction targets

Hypertension

Click here for more information on Hypertension

Brand of the Year Frontline pet parasiticides

FRONTLINE® Wins Brand of the Year Award for the Third Time in a row

Grow Your Skills

Great things in business are never done by one person; they’re done by a team of people

How Boehringer Ingelheim has responded to the pandemic

As part of the pharmaceutical industry, Boehringer Ingelheim joined the collective efforts in fighting COVID-19 ever since the start of the pandemic.

Lifelong learning at our Virtual Campus

The Virtual Campus of our Boehringer Ingelheim University supports our employees in their personalized lifelong learning.

Overcoming heartworm disease for homeless pets

Heartworm-free pets soar to new lives. Together with our Greater Good Charity partners, our colleagues helped bring shelter dogs to forever homes.

Avian influenza 5 things you should know

Communities across the globe are faced with outbreaks of bird flu. We stand with poultry farmers and veterinarians and supports the effort against the disease

cat feline diabetes medication treatment eu approval

Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats

Results for Jardiance EMPACT-MI phase III trial

Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack

Advances in vectored vaccines for poultry

Vaccine design technologies have made huge advances in recent years. One of the newer categories of vaccine, vectored vaccines, is overcoming challenges that conventional vaccines do not meet.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers